US Broker Ratings

Abivax SA (ABVX) Stock Analysis: Exploring a 28.41% Upside in the Biotech Sector

In the dynamic world of biotechnology, Abivax SA (ABVX) stands out not only for its ambitious clinical trials but also for its potential to offer investors..

Humacyte, Inc. (HUMA) Stock Analysis: Unveiling a Potential 571.55% Upside in the Biotech Sector

Humacyte, Inc. (NASDAQ: HUMA) is a pioneering biotechnology company that stands at the forefront of revolutionary advancements in the healthcare sector. With its proprietary technology platform..

REGENXBIO Inc. (RGNX) Stock Analysis: Exploring a 107% Potential Upside in the Biotech Sector

Investors with a keen eye on the biotechnology sector should keep REGENXBIO Inc. (NASDAQ: RGNX) on their radar. With a market capitalization of $759.35 million, this..

Nuvation Bio Inc. (NUVB) Stock Analysis: 32.81% Potential Upside Sparks Investor Interest

Investors with an eye on the healthcare sector may find Nuvation Bio Inc. (NASDAQ: NUVB) an intriguing option. The clinical-stage biopharmaceutical company is making waves in..

Dianthus Therapeutics (DNTH) Investor Outlook: A Biotechnology Gem with a 66.92% Upside

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) has emerged as a remarkable player in the biotechnology sector, capturing the attention of investors with its promising prospects in the..

Maze Therapeutics (MAZE) Stock Analysis: Exploring a 21.52% Potential Upside with Strong Buy Ratings

Maze Therapeutics, Inc. (NASDAQ: MAZE) is catching the eye of investors with its compelling blend of innovative biotechnology solutions and a notable potential upside of 21.52%...

Upstream Bio, Inc. (UPB) Stock Analysis: A 72.74% Potential Upside in the Biotechnology Sector

In the dynamic world of biotechnology, Upstream Bio, Inc. (NASDAQ: UPB) is emerging as a noteworthy player. With an impressive 72.74% potential upside, the company has..

RxSight, Inc. (RXST) Investor Outlook: A Close Look at Its 7.98% Potential Upside

RxSight, Inc. (RXST) is making waves in the healthcare sector with its innovative approach to enhancing visual acuity post-cataract surgery. As a commercial-stage medical technology company,..

Bioventus Inc. (BVS) Stock Analysis: A Compelling 87.50% Upside Potential in the Healthcare Sector

Investors with an eye on the healthcare sector might want to take a closer look at Bioventus Inc. (BVS). With its focus on innovative medical devices,..

Prothena Corporation plc (PRTA) Stock Analysis: Exploring a Strong 124.68% Potential Upside in Biotechnology

Prothena Corporation plc (NASDAQ: PRTA), a clinical-stage biotechnology company specializing in the development of therapies for protein dysregulation diseases, has captured the attention of investors with..

CeriBell, Inc. (CBLL) Stock Analysis: Healthcare Innovator with a 21.99% Upside Potential

CeriBell, Inc. (NASDAQ: CBLL), a company at the forefront of medical technology, is making significant strides in the healthcare sector, particularly in the niche of neurological..

Ardelyx, Inc. (ARDX) Stock Analysis: Exploring an 84% Potential Upside in Biotech

Ardelyx, Inc. (NASDAQ: ARDX), a biotechnology company headquartered in Waltham, Massachusetts, has captured the attention of individual investors with its promising pipeline targeting unmet medical needs...

PureTech Health plc (PRTC) Stock Analysis: Revenue Growth Surges Over 540% as Biotech Innovator Advances Key Therapies

For investors with an eye on groundbreaking biotechnology developments, PureTech Health plc (NASDAQ: PRTC) presents an intriguing case. Situated in the heart of the biotech sector,..

Standard BioTools Inc. (LAB) Stock Analysis: Navigating Challenges with Innovative Technology in Medical Devices

For investors eyeing opportunities in the healthcare sector, Standard BioTools Inc. (NASDAQ: LAB) presents a compelling, albeit challenging, proposition. With a market capitalization of $592.23 million,..

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a 131% Upside Potential in the Telehealth Sector

LifeMD, Inc. (NASDAQ: LFMD) stands at a pivotal juncture in the burgeoning telehealth industry. As a direct-to-patient telehealth company, LifeMD connects consumers with healthcare professionals, offering..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: A 70% Upside Potential in the Healthcare Sector

Amylyx Pharmaceuticals, Inc. (AMLX) is capturing the attention of investors with its promising potential upside, currently estimated at 70.94%. This clinical-stage pharmaceutical company, based in Cambridge,..

Claritev Corporation (CTEV) Stock Analysis: Exploring a Potential 172% Upside in Healthcare Analytics

Claritev Corporation (CTEV), a key player in the healthcare industry, has carved out its niche with a focus on data analytics and technology-enabled solutions for cost..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Unraveling a 224% Potential Upside for Biotech Investors

Bicycle Therapeutics plc (NASDAQ: BCYC) is capturing the attention of biotech investors with its striking potential for a 224.28% upside, according to the latest analyst consensus...

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring a 100% Upside Potential in the Biotech Sector

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stands out in the biotechnology industry with its bold approach to developing gene therapies for rare and life-threatening diseases. As a..

Avadel Pharmaceuticals plc (AVDL) Stock Analysis: Navigating Growth with a 54.90% Revenue Surge and Strategic Focus

Avadel Pharmaceuticals plc (NASDAQ: AVDL) is making waves in the healthcare sector, particularly in the niche market of specialty and generic drug manufacturing. With its headquarters..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds